BIIB Chart BIIB data by YCharts

Biogen Idec ( BIIB): Cramer also interviewed this company's CEO and came way as excited as ever about its life-altering drug pipeline.

If you liked this article you might like

Stalking Regeneron for Key Low and Reversal

Regeneron Pharmaceuticals Ready to Make All-Time Highs

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Biotech movers: CEL-SCI Leaps After FDA Lets Cancer Study Move Forward

If It's Not Earnings News, It's Amazon Competition: Jim Cramer's Best Blog